High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|13|1480-1493

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.13, 2010-05, pp. : 1480-1493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic agents that raise high-density lipoprotein cholesterol levels

By Rodriguez Annabelle   Doshi Rajiv R  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 167-175

Informa Healthcare

Access to resources Recommend Favorite

Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target

By Macphee Colin   Benson G Martin   Shi Yi   Zalewski Andrew  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic use of the high-density lipoprotein protein and peptides

By Marchesi Marta   Sirtori Cesare R  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 227-241

Informa Healthcare

Access to resources Recommend Favorite

The endothelin system:a novel therapeutic target in cardiovascular disease

By Strachan F.E.   Webb D.J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 95-112

Informa Healthcare

Access to resources Recommend Favorite